CMI - Centers for Medical Innovation AG

CMI AG is a bioscience company that is engaged in the identification, development and commercialization of a new generation of plant derived prescription drugs for the treatment of serious chronic diseases such as chronic hepatitis B and C, Parkinsons Disease. CMI AG first began operations in Ocotber 1997 and has currently two plant products in development. Exclusive Options on two more promising late stage plant products have been signed.

Contact Details: Fraunhoferstr. 15 Martinsried / Munich Bavaria D-82152 Germany Tel: +49 - 89 - 8565 1600 Fax: +49 - 89 - 8565 1601 Email: s_huebschmann@centersmi.com WWW: www.rsmedical.com/

Recent Publications by CMI - Centers for Medical Innovation AG:
Inhibition of wild-type human immunodeficiency virus and reverse transcriptase inhibitor-resistant variants by Phyllanthus amarus. Substantial progress has been made in research on natural products which...	18th September, 2003	CMI-Centers for Medical Innovation AG, Fraunhofer Str 15, 82152	Antiviral Res. 2003 Apr;58(2):175-86.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 240 times since April 2007, the link to the organisation's website has been followed 52 times

Recent Search Terms used to find this page: centers for medical innovation germany | cmi centers for medical innovation | CMI Martinsried | CMI AG | CMI-Centers for Medical Innovation AG | Centers for Medical Innovation | Centers for Medical Innovation | Centers for Medical Innovation | Centers for Medical Innovation | .

Search for more companies in Martinsried / Munich

Search for more companies in Bavaria

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for CMI - Centers for Medical Innovation AG